Copyright
©The Author(s) 2021.
World J Clin Cases. Nov 26, 2021; 9(33): 10143-10150
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10143
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10143
GRACE risk scores (points) | n | Medication group | Stent group | CABG group | Overall MACE rate | Hc value | P value | |||
n | MACE rate | n | MACE rate | n | MACE rate | |||||
Low risk group (0-88) | 95 | 65 | 4 (6.2) | 25 | 7 (28.0) | 5 | 2 (40.0) | 13 (13.7) | 5.231 | 0.041 |
Intermediate risk group (89-117) | 151 | 71 | 22 (31.0) | 66 | 20 (30.3) | 14 | 6 (42.9) | 48 (31.8) | 2.742 | 0.086 |
High risk group (≥ 118) | 140 | 59 | 10 (16.9) | 65 | 30 (46.2) | 16 | 7 (43.8) | 47 (33.6) | 5.381 | 0.040 |
Total | 386 | 195 | 36 (18.5) | 156 | 57 (36.5) | 35 | 15 (42.9) | 108 (28.0) | 4.412 | 0.044 |
- Citation: Wang XF, Zhao M, Liu F, Sun GR. Value of GRACE and SYNTAX scores for predicting the prognosis of patients with non-ST elevation acute coronary syndrome. World J Clin Cases 2021; 9(33): 10143-10150
- URL: https://www.wjgnet.com/2307-8960/full/v9/i33/10143.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i33.10143